APELLIS PHARMACEUTICALS INC - NASDAQ: $APLS Knocking On Door
After breaking-out in early Spring (March), APELLIS PHARMACEUTICALS INC - NASDAQ:APLS has been building-out its right side in a prolonged base and presently finds itself nearing a potential move that may just catapult the stock into higher ground as evidenced in the Daily chart above.
While further work is required, APLS presently trades above all of its important moving averages 20/50/200 DMA's, which depicts a healthy technical posture.
Additionally, when one extends the time-frame out to the Weekly chart, we can also observe that APLS is presently knocking on the door to a potential move out of its long-drawn base.
Thus, both investors/traders may want to pay close attention to the action in the days/weeks ahead for further clues/evidence that APLS may just be on the verge of breaking free from its base.
Should APLS be capable of going topside of the $22.25 figure at any time in the days ahead, such development, should it occur, would like trigger its next meaningful advance into higher ground with and initial $24-$26 objective and perhaps higher.
While further work is required, APLS presently trades above all of its important moving averages 20/50/200 DMA's, which depicts a healthy technical posture.
Additionally, when one extends the time-frame out to the Weekly chart, we can also observe that APLS is presently knocking on the door to a potential move out of its long-drawn base.
Thus, both investors/traders may want to pay close attention to the action in the days/weeks ahead for further clues/evidence that APLS may just be on the verge of breaking free from its base.
Should APLS be capable of going topside of the $22.25 figure at any time in the days ahead, such development, should it occur, would like trigger its next meaningful advance into higher ground with and initial $24-$26 objective and perhaps higher.
To receive our alerts via email and SMS, join Insider Financial for Free at signup.insiderfinancial.com
We are not financial advisors. Always conduct your own research and read our full disclaimer at insiderfinancial.com/disclaimer/
We are not financial advisors. Always conduct your own research and read our full disclaimer at insiderfinancial.com/disclaimer/
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.